Market Tracker

07/03 4:45pm ET

PowerShares Golden Dragon China Portfolio (PGJ)

32.81
Delayed Data
As of Jul 02
 -0.22 / -0.67%
Today’s Change
26.93
Today|||52-Week Range
36.36
+17.81%
Year-to-Date

Investment Objective

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the NASDAQ Golden Dragon China Index. The fund generally will invest at least 90% of its total assets in equity securities of companies deriving a majority of their revenues from the People's Republic of China and that comprise the underlying index. The underlying index is composed of securities of U.S. exchange-listed companies that are headquartered or incorporated in the People's Republic of China. It is non-diversified.

Performance

1 month-4.06% 3 years+21.44%
3 months+8.43% 5 years+9.25%
1 year+4.57% Since inception+9.18%
Data through 07/03/2015

Quote Details

Previous close$33.03
Open day’s range32.62 – 33.05
Net asset value (NAV)32.80 (07/02/2015)
Daily volume19,849
Average volume (3 months)46,407
Data as of 3:59pm ET, 07/02/2015

Peer Comparisonvs. China region ETFs

 PGJCategory
Performance 5-yr return+9.25%+3.65%
Expense Gross exp ratio0.70%0.70%
Risk 5 year sharpe ratio0.500.48
Net assets$229.2M$668.1M
Average market cap$7.6B$38.9B
Average P/E20.212.8
Dividend / Share--0.37%

Competitors

EWH iShares MSCI Hong Kong ETF
FHK First Trust Hong Kong AlphaDEX┬« Fund
EWT iShares MSCI Taiwan ETF

Holdings

Top 5 Sectors
Portfolio weighting
Telecommunication 27.14%
Energy 21.45%
Business service 9.78%
Industrial materials 9.64%
Hardware 5.77%
Top 10 Holdings
Portfolio weighting
CTRP Ctrip.Com International Ltd10.64%
NTES NetEase, Inc9.29%
VIPS Vipshop Holdings Ltd6.81%
BIDU Baidu6.46%
CHL China Mobile6.07%
QIHU Qihoo 360 Technology Co Ltd3.80%
YOKU Youku Tudou Inc3.15%
EDU New Oriental Education & Technology Group Inc3.00%
WX WuXi PharmaTech (Cayman) Inc2.78%
CBPO China Biologic Products Inc2.46%